Cargando…
Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics
Since November 2019 the SARS-CoV-2 pandemic has caused nearly 200 million infection and more than 4 million deaths globally (Updated information from the World Health Organization, as on 2(nd) Aug 2021). Within only one year into the pandemic, several vaccines were designed and reached approval for...
Autores principales: | Kumar, Sriram, Çalışkan, Duygu Merve, Janowski, Josua, Faist, Aileen, Conrad, Beate Claudine Gisela, Lange, Julius, Ludwig, Stephan, Brunotte, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519339/ https://www.ncbi.nlm.nih.gov/pubmed/34659259 http://dx.doi.org/10.3389/fimmu.2021.752227 |
Ejemplares similares
-
Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond
por: Faist, Aileen, et al.
Publicado: (2022) -
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier
por: Faist, Aileen, et al.
Publicado: (2023) -
Phosphorylation of TRIM28 Enhances the Expression of IFN-β and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial Cells
por: Krischuns, Tim, et al.
Publicado: (2018) -
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses
por: Schreiber, André, et al.
Publicado: (2022) -
3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases
por: Schloer, Sebastian, et al.
Publicado: (2022)